Betta Pharmaceuticals | ApexOnco - Clinical Trials news and analysis

x

“The insights provided by the analysts are great”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Regulatory

9 August 2024

Lilly is down but not out of PI3K alpha inhibition

Trial results

31 January 2024

Novartis calls time on TIM-3 and HIF2α

The company’s move could be a warning for rivals including GSK, AstraZeneca and Incyte.

Trial results

1 September 2023

Roche could take another targeted treatment into adjuvant lung cancer

Subscribe to Betta Pharmaceuticals